Quebec Class Action On December 23, 2025, Siskinds Desmeules filed an application for authorization to institute a class action before the Superior Court of Quebec, alleging manufacturer liability on the part of Eli Lilly for the safety defects with the drugs Mounjaro, Trulicity, and Zepbound in that there was a lack of sufficient indications as to the health risks and dangers they involve or as to the means to avoid them, in particular the risks of gallbladder disorders, severe gastrointestinal injuries (including gastroparesis, or stomach paralysis), blood clots, aspiration during surgery, necrotizing pancreatitis, vision loss (non-arteritic anterior ischemic optic neuropathy), and malnutrition
Research Findings on AOD-9604 Key findings from preclinical research include: Lipolytic activity: Stimulates fat breakdown in adipocyte cultures and animal models
This is where peptide therapy shows promise
Neuroprotection in rats following ischaemia-reperfusion injury by Glp-1 analogues-liraglutide and semaglutide
There are some vegan options on the market
A krnikus alvshiny tnkretette a koncentrcimat elfordult, hogy ra kzben egyszeren lefagytam, s elfelejtettem, mit magyarztam ppen
